MicroRNAs are beneficial for cancer therapy as they can simultaneously downregulate multiple targets involved in diverse biological pathways related to tumor development. In papillary thyroid cancer, many microRNAs were identified as differentially expressed factors in tumor tissues. In another way, recent studies revealed cell proliferation, cell cycling, apoptosis, and autophagy are critical pathways controlling papillary thyroid cancer development and progression. As miR-524-5p was approved as a cancer suppressor targeting multiple genes in several types of cancer cells, this study aims to characterize the role of miR-524-5p in the thyroid cancer cell. The expression of miR-524-5p was decreased in the papillary thyroid cancer tissues and cell lines, while forkhead box E1 (FOXE1) and ITGA3 were increased. In the clinical case, expression of miR-524-5p, FOXE1, and ITGA3 were significantly correlated with papillary thyroid cancer development and progression.
cell-cycle progression were also involved in the PTC progression.
After decades of studies in molecular biology, researchers have identified several oncogenes related proliferation and cell cycle of cancer cell, such as LCN2, CRABP1, C1QL1, PTEN, and BRAF (Celestino et al., 2018; Loo, Khalili, Beuhler, Siddiqi, & Vasef, 2018; Razavi, Modarressi, Yaghmaei, Tavangar, & Hedayati, 2017) . In recent years, it was implicated that autophagy has a vital role in PTC development and progression. Without FAM129A induced autophagy in normal thyroid cells, carcinomas are developed under certain nutrient and growth condition (Nozima et al., 2019) . miR-125b could enhance autophagy in PTC through repression of Foxp3 . miR-144 reduces the tumor growth by suppressing transforming growth factor-α signaling pathway to promote autophagy of PTC (J. Liu et al., 2018) . Obviously, targets for PTC therapy exist in multiple biological pathways. Both EMT and autophagy attracted researchers' attention to survey underline mechanisms related to PTC development and progression.
In the complicated network of carcinoma development, microRNAs (miRNAs) have the critical role as they can simultaneously downregulate multiple targets (Dallaire, Frederick, & Simard, 2018; Fitzwalter et al., 2018; Kasper et al., 2017; Singh, Lee, Hartman, RuizWhalen, & O'Reilly, 2018) . Thus, it is possible to modify cell proliferation, cycling, and autophagy in carcinoma cells at the same time though controlling miRNAs expression. In PTC, there are several differentially expressed miRNAs were identified by miRNA sequencing (Graham et al., 2015) . PTC cell proliferation is prevented by miR-7 targeting CDC28 protein kinase regulatory subunit 2 (CKS2) (Hua et al., 2016) . This interaction also influences on the migration and invasion of PTC. Whereas, miR-150-5p targeting on BRAFV600E mutation could accelerate PTC development by enhancing EMT . During the processes, the PTC cell proliferation and apoptosis are also affected by miR-150-5p with regulation on BRAFV600E. The typical tumor pathway AKT/mTOR in PTC development and progression is also regulated by miR-451a (Minna et al., 2016) . To turn down the activation of AKT/mTOR pathway, multiple targets including AKT1, MIF, and c-MYC are downregulated by miR-451a. Attenuated AKT/mTOR signaling pathway through ectopic expression of miR-451a could damage the processes of PTC cell proliferation and migration. Another typical miRNA function as a tumor suppressor in PTC is let-7 miRNA targeting on RAS. Recent studies suggested that the let-7 family from circulating miRNA could be served as a clinical marker to noninvasively diagnose PTC and prognose survival after treatment (Perdas, Stawski, Nowak, & Zubrzycka, 2016) .
Using developed sequencing biotechnology on clinical samples, more miRNAs were determined as differentially expressed miRNAs in the PTC compared with normal thyroid tissue. There is still unknown mechanism effecting PTC development and progression related to miRNA remained to be studied. miR-524-5p that has been ). The growth of glioma is decreased by miR-524-5p targeting on EZH2, Jagged-1, and Hes-1 (L. Chen et al., 2012; Zhi et al., 2017) .
Oncogene BRAF and ERK2 could be downregulated by miR-524-5p in melanoma to reduce tumor growth (S. M. Liu, Lu, Lee, Chung, & Ma, 2014) . However, the role of miR-524-5p is still unclear in PTC where miR-524-5p was already detected with differential expression level.
In this study, we investigated the relationship between miR-524-5p and PTC development and uncovered the underlying mechanisms by identification of its major targeting genes and biological pathway.
| MATERIALS AND METHODS

| Patients and tissue sample
PTC and para-PTC tissues were received from Affiliated Union Hospital of Fujian Medical University (Fuzhou, China) and stored at −80°C. All experiments in this study were approved by the Ethics Committee of the Affiliated Union Hospital of Fujian Medical University. Before studies, informed consents were signed by all patients providing samples in this study. All patients were diagnosed and examined by the Affiliated Union Hospital of Fujian Medical University (Fuzhou, China) with at least two pathologists. 
| Cell lines
| RNA extraction and isolation
TRIzol Reagent (Thermo Fisher Scientific, Waltham, MA), NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific) and the Agilent RNA 6000 (Thermo Fisher Scientific) Nano assay was utilized to isolate the total RNA and assess the RNA quantity, purity, and integrity. The experiments performed following the manufacturer's instructions. Gel electrophoresis was used to detect genomic DNA contamination. RNA with A260/A280 ≥ 1.6 and A260/A230 ≥ 1 were used for the following experiments.
| Real-time quantitative PCR (RT-qPCR)
The complementary DNA was produced by the Prime Script™ Tween-20, 5% nonfat-milk, and 150 mM NaCl) was applied on membranes for 2 hr at room temperature. After three times phosphate-buffered saline with Tween 20 (PBST) buffer washing, primary antibodies were applied for 2 hr incubation. Next four times PBST buffer washing, the secondary antibody were added for overnight incubation. Next four times PBST buffer washing,
BioTECH, Nanjiang, China) was utilized for detection of blots.
| Luciferase reporter assay
3′ untranslated region (3′UTR) of matrilin 2 (MATN2), forkhead box E1 (FOXE1), and ITGA3 including the predicted miR-524-5p binding site was amplified and constructed into the psiCHECK-2 reporter vector (Promega, Madison, WI). Also, mutant version was produced.
After cotransfection with miR-524 mimics, Luciferase activity was determined by Dual-Luciferase Reporter Assay Kit (Promega).
| Cell transfection
miR mimics and inhibitor, RNAi were generated by Shanghai Jima was used to cell proliferation assay. In colony formation assay, cell was grown in six-well transwell plates for 2 weeks. Crystal violet solution (0.5%) was used to stained the positive cells after fixation.
For scratch test, A 10 μl pipet tip was used to make lines and after certain hours, cells were imaged and determine the distance of gap.
All assays were carried out biological independently in triplicate.
| Cell cycle and apoptosis analysis
After washing with PBS, cells were fixed in 75% ethanol at 4°C
overnight. Again washed with PBS, propidium iodide was used to stain cell in the dark at 37°C. Flow Cytometry (Beckman Coulter, Inc., Brea, CA) was used to measure the cell populations in different phases. To determine the cell apoptosis, Annexin V-FITC To determine the miR-524-5p expression in cancer and papa-cancer tissues, RT-qPCR was carried out with tissues from 57 PTC patients.
Results displayed that expression of miR-524-5p in PTC was lower than adjacent normal tissues with a significant fold change < 0.3 
| The progression of PTC is associated with the level of miR-524-5p
The clinical characteristics of PTC patients were collected for further analysis of the relationship between the PTC progression and miR-524-5p, FOXE1, or ITGA3 expression. According to the age, gender, tumor size, degree of differentiation, lymph node metastases (LNM), degree of invasion, and TNM stage, patients were grouped and averaged expression levels of miR-524-5p was used to compare differences ( Table 1) . The significantly lower levels of miR-524-5p
were detected in LNM, intrathyroid carcinoma and I-II TNM stages (p < 0.05).
3.4 | FOXE1 and ITGA3 are target genes of miR-524-5p in PTC cells group were increased and decreased, respectively (p < 0.05; Figure   5a ,b). Other groups had no significant differences in the pattern of cell cycle (Figure 5a,b) .
3.8 | PTC cell apoptosis was enhanced by miR-524-5p, FOXE1, or siRNA-ITGA3
To survey the effect of miR-524-5p, FOXE1, and ITGA3 on PTC cell apoptosis, apoptosis rate of TPC-1 and NPA under different transfection were determined by flow cytometry. Results showed F I G U R E 3 Cell viability of TPC-1 (a) and NPA (b) cells with certain preprocesses were determined by MTT assay. miR-524-5p mimic groups showed decreased cell viability in both TPC1 and NPA cells (p < 0.05), while miR-524-5p inhibitor groups increased. siRNA-FOXE1 and siRNA-ITGA3 groups have reduced cell viabilities (p < 0.05). FOXE1: forkhead box E1; MTT: 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide; siRNA: small interfering RNA [Color figure can be viewed at wileyonlinelibrary.com] F I G U R E 4 Cell migration and invasion of miR-524-5p, FOXE1, and ITGA3 in TPC-1 (a) and NPA (b) cells were determined by scratch test and transwell assay. miR-524-5p mimic group showed decreased numbers of migration and invasion cells, while miR-524-5p inhibitor groups showed significantly increased numbers. Both siRNA-FOXE1 and siRNA-ITGA3 groups showed reduced cell numbers (p < 0.05). FOXE1: forkhead box E1; siRNA: small interfering RNA that the apoptosis rate of TPC-1 and NPA was significantly increased in miR-524-5p mimic groups (Figure 5c ). miR-524-5p inhibitor groups in NPA significantly reduce the apoptosis rate (Figure 5c ). Both siRNA-FOXE1 and siRNA-ITGA3 groups had increased apoptosis rate in apoptosis rate (Figure 5c ).
3.9 | Autophagy-related protein and cycle cyclin-dependent kinase are regulated by miR-524-5p
To analysis the relationship between autophagy and miR-524-5p, autophagy-related protein level was determined by western blot analysis in TPC-1 and NPA under different transfection. Results
showed that LC3-II and BECLIN1 were significantly increased in miR-524-5p mimic group while decreased in miR-524-5p inhibitor group (Figure 6a,b) . siRNA-FOXE1 group has the similar result of LC3-II and BECLIN1 to miR-524-5p mimic group with downregulated FOXE1 protein level (Figure 6a,b) . B-cell lymphoma-2 (Bcl-2) was decreased in miR-524-5p mimic and siRNA-FOXE1 groups, while increased in miR-524-5p inhibitor group (Figure 6a,b) . siRNA-ITGA3 group shows no change on LC3-II, BECLIN1, and Bcl-2 with downregulated ITGA3 protein level (Figure 6a (Minna et al., 2016) . In glioma, miR-524-5p could also directly knockdown expression of EZH2, Jagged-1, and Hes-1 (L. Chen et al., 2012; Zhi et al., 2017) . Thus, our results confirmed that both ITGA3 and FOXE1 are targets of miR-524-5p in PTC development.
Second, miR-524-5p, ITGA3, and FOXE1 established a suppression pathway on PTC development and progression. In this study, miR- (Table 1) . ITGA3 has been identified as a factor to enhance cell proliferation and cell cycle in intrahepatic cholangiocarcinoma (Huang et al., 2018) . ITGA3 could also play in bladder cancer to regulate cell apoptosis (Sakaguchi et al., 2017) . In contrast, previous Genome-Wide Association Study suggested that SNP in FOXE1 is strongly associate with the risk of PTC (He et al., 2015) . Together, these results reveal a potential mechanisms underlying suppression of PTC progression through miR-524-5p,
ITGA3
, and FOXE1 pathway.
Third, ITGA3 or FOXE1 might play in a different role during PTC development. In MTT assay, miR-524-5p mimic has more effect than RNAi-ITGA3 or RNAi-FOXE1 alone (Figure 3) . The protein level of autophagy-related protein LC3-II, Bcl-2, and BECLIN1 are changed under the regulation of miR-524-5p or FOXE1 but not ITGA3 (Figure 6 ). The effect of FOXE1 on cell cycle might be attenuated that ITGA3 (Figure 6 ). Recent studies reveal that the increase of FOXE1 is associated with autophagy markers such as LC3B, ATG5, ATG12, and BECLIN1 (Ji, Cui, Yu, & Cui, 2016) . Taken together, ITGA3, and FOXE1 might effect on cell cycle and autophagy, respectively.
In conclusion, FOXE1 and ITGA3 are direct targets of miR-524-5p
in PTC. miR-524-5p could suppress PTC progression by regulating tumor cell proliferation, migration, and invasion. During the suppression, miR-524-5p downregulate FOXE1 and ITGA3 to enhance the PTC cell apoptosis. Also, PTC cell-cycle arrest and autophagy might be controlled by miR-524-5p/ITGA3 and miR-524-5p/FOXE1, respectively.
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